Revolutionizing drug Discovery With Cutting-Edge Technologies

Abstract

This chapter discusses the transformative potential of cutting-edge technologies in revolutionizing drug discovery processes, highlighting key issues and challenges anticipated in the next decade. The integration of technologies such as artificial intelligence (AI), high-throughput screening, CRISPR/Cas9 gene editing, and advanced analytics is poised to reshape the landscape of pharmaceutical research, promising accelerated development timelines and enhanced therapeutic outcomes. Artificial intelligence, particularly machine learning algorithms, plays a central role in data analysis, target identification, and drug repurposing. High-throughput screening technologies enable the rapid evaluation of large compound libraries, expediting the identification of lead compounds and optimizing drug development pipelines. CRISPR/Cas9 gene editing provides unprecedented precision in modifying genetic material, opening avenues for the development of more targeted and personalized therapies.